Kadmon Holdings, Inc. (KDMN) financial statements (2022 and earlier)

Company profile

Business Address 450 EAST 29TH STREET
NEW YORK, NY 10016
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 134,422181,59494,74067,51736,093
Cash and cash equivalents 74,423139,59794,74067,51736,093
Short-term investments 59,99941,997   
Receivables 6959541,6901,1861,210
Inventory, net of allowances, customer advances and progress billings 1026409252011,950
Inventory 1026409252011,950
Deferred costs     56
Other undisclosed current assets 2,0821,4161,5811,109978
Total current assets: 137,301184,60498,93670,01340,287
Noncurrent Assets
Operating lease, right-of-use asset 16,11219,651
Property, plant and equipment 1,2872,4443,6544,2925,427
Long-term investments and receivables 2,3002,3002,3003,50011,100
Long-term investments 2,3002,3002,3003,50011,100
Intangible assets, net (including goodwill) 3,5803,5803,580(137,120)(137,120)
Goodwill 3,5803,5803,5803,5803,580
Intangible assets, net (excluding goodwill)    (140,700)(140,700)
Restricted cash and investments 2,1172,1162,1162,1162,116
Other noncurrent assets 13103 95
Other undisclosed noncurrent assets   34,075140,742140,741
Total noncurrent assets: 25,40930,19445,72513,53922,269
TOTAL ASSETS: 162,710214,798144,66183,55262,556
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 22,46723,29123,49416,58518,446
Accounts payable 10,9339,0439,9868,0086,296
Accrued liabilities 11,53414,24813,5088,57712,150
Debt 1,6993,966 33,707 
Derivative instruments and hedges, liabilities 1,0821,4855241,952 
Deferred revenue and credits4,4004,400
Other undisclosed current liabilities 4,223   1,900
Total current liabilities: 29,47128,74224,01856,64424,746
Noncurrent Liabilities
Long-term debt and lease obligation 16,93819,75927,480 28,677
Long-term debt, excluding current maturities 1,359 27,480 28,677
Operating lease, liability 15,57919,759
Liabilities, other than long-term debt 2785624,75225,15034,325
Deferred revenue and credits23,96428,394
Deferred rent credit   4,290
Deferred tax liabilities, net4159391,376
Deferred income tax liabilities 278461
Other liabilities  101472471,250
Derivative instruments and hedges, liabilities     3,305
Total noncurrent liabilities: 17,21620,32132,23225,15063,002
Total liabilities: 46,68749,06356,25081,79487,748
Stockholders' equity
Stockholders' equity attributable to parent 116,023165,73588,411(38,462)(63,539)
Preferred stock 44,55542,43342,231  
Common stock 17116011379 
Additional paid in capital 515,429456,211315,710198,85692,166
Accumulated other comprehensive loss (28)    
Accumulated deficit (444,104)(333,069)(269,643)(237,397)(155,705)
Other undisclosed stockholders' equity    40,22038,347
Total stockholders' equity: 116,023165,73588,4111,758(25,192)
TOTAL LIABILITIES AND EQUITY: 162,710214,798144,66183,55262,556

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues 8,2885,0951,39612,26426,055
Revenue, net12,26426,055
Gain on disposition of assets for financial service operations 19,78422,000 
Cost of revenue
(Cost of Goods and Services Sold)
 (851)(912)(682)(1,654)(385)
Other undisclosed gross profit (1,150)(377) (1,332)(3,485)
Gross profit: 6,2873,8067149,27822,185
Operating expenses (108,568)(92,886)(86,610)(77,834)(137,589)
Operating loss: (102,281)(89,080)(85,896)(68,556)(115,404)
Nonoperating income (expense) (6,814)27,75831,120(11,339)(93,009)
Investment income, nonoperating 1,5941,10636,9072,2284,418
Interest and debt expense 3,684(3,381)(4,619)(5,962)(11,176)
Loss from continuing operations before equity method investments, income taxes: (105,411)(64,703)(59,395)(85,857)(219,589)
Other undisclosed income (loss) from continuing operations before income taxes (3,684)3,3814,6195,96211,176
Loss from continuing operations before income taxes: (109,095)(61,322)(54,776)(79,895)(208,413)
Income tax expense (benefit) 182(46)524121(342)
Net loss attributable to parent: (108,913)(61,368)(54,252)(79,774)(208,755)
Preferred stock dividends and other adjustments (2,122)(2,058)(2,011)(1,918)(21,733)
Net loss available to common stockholders, basic: (111,035)(63,426)(56,263)(81,692)(230,488)
Dilutive securities, effect on basic earnings per share    26,54910,958
Net loss available to common stockholders, diluted: (111,035)(63,426)(56,263)(55,143)(219,530)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss: (108,913)(61,368)(54,252)(79,774)(208,755)
Other comprehensive loss (28)    
Other undisclosed comprehensive loss (2,122)    
Comprehensive loss, net of tax, attributable to parent: (111,063)(61,368)(54,252)(79,774)(208,755)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: